Encompass Health Is Healthy Enough To Justify A Bullish View
Encompass Health Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
Encompass Health's capacity expansion, new facilities and North Carolina pipeline could fuel 6-8% multi-year discharge growth.
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health Q2 Earnings Call Highlights
Encompass Health NYSE: EHC reported second-quarter 2026 results marked by revenue, earnings and discharge growth, prompting the inpatient rehabilitation provider to raise its full-year outlook.
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Compared to Estimates, Encompass Health (EHC) Q2 Earnings: A Look at Key Metrics
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Encompass Health (EHC) Beats Q2 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.4 per share a year ago.
Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?
Hospital operator Encompass Health Corporation EHC is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $1.48 per shareon revenues of $1.57 billion.
